Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy
Not Applicable
Active, not recruiting
- Conditions
- Ovarian Carcinoma
- Registration Number
- NCT04310826
- Lead Sponsor
- M.D. Anderson Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Inclusion Criteria:<br><br> - Patients with previously untreated ovarian cancer.<br><br> - Receiving carboplatin-containing chemotherapy of at least 6 consecutive cycles.<br><br> - Able to tolerate an oral diet.<br><br>Exclusion Criteria:<br><br> - Prior platinum-based chemotherapy.<br><br> - Serum creatinine level > 1.4 mg/dL prior to treatment.<br><br> - Artificial nutrition (e.g. Ensure or Boost) accounts for > 50% of total calorie<br> intake.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient retention rate;Dietary adherence rate
- Secondary Outcome Measures
Name Time Method Occurrence of hypomagnesemia;Need for a pharmacy intervention including oral and intravenous magnesium dosage